Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Nixon

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cellular and Molecular Life Sciences : CMLS|November 18, 1998
T-cell signal transduction and the role of protein kinase CS E Wilkinson, J S Nixon
ISA Transactions|January 1, 1986
Decision tables in process control: a powerful development toolJ S Nixon, W L McMullen
Expert Opinion on Investigational Drugs|November 4, 2000
Metalloproteinase inhibitors: new opportunities for the treatment of rheumatoid arthritis and osteoarthritisT Shaw, J S Nixon, K M Bottomley
Journal of Molecular Biology|July 5, 1981
Mutational variants of the Neurospora crassa NADP-specific glutamate dehydrogenase altered in a conformational equilibriumB Ashby, J S Nixon, J C Wootton
The Biochemical Journal|September 1, 1993
Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase CS E Wilkinson, P J Parker, J S Nixon
Agents and Actions|January 1, 1993
Therapeutic potential of protein kinase C inhibitorsD Bradshaw, C H Hill, J S Nixon, et al.
Agents and Actions|January 1, 1986
The inhibitory profiles of hog pancreatic and human rheumatoid synovial cell phospholipases A2J S Nixon, S E Wilkinson, P Davis, et al.
Biochimica Et Biophysica Acta|July 27, 1989
1H-NMR and protection studies of interactions between ligands and bovine pancreatic phospholipase A2M P Williamson, P D Davis, M J Broadhurst, et al.
Cellular Signalling|January 1, 1997
Different sensitivities of neutrophil responses to a selective protein kinase C inhibitor Ro 31-8425; redundancy in signal transductionJ E Merritt, J A Sullivan, J Tse, et al.
Agents and Actions|March 1, 1991
Modulation of cellular processes by H7, a non-selective inhibitor of protein kinasesJ S Nixon, S E Wilkinson, P D Davis, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cellular and Molecular Life Sciences : CMLS|November 18, 1998
T-cell signal transduction and the role of protein kinase CS E Wilkinson, J S Nixon
ISA Transactions|January 1, 1986
Decision tables in process control: a powerful development toolJ S Nixon, W L McMullen
Expert Opinion on Investigational Drugs|November 4, 2000
Metalloproteinase inhibitors: new opportunities for the treatment of rheumatoid arthritis and osteoarthritisT Shaw, J S Nixon, K M Bottomley
Journal of Molecular Biology|July 5, 1981
Mutational variants of the Neurospora crassa NADP-specific glutamate dehydrogenase altered in a conformational equilibriumB Ashby, J S Nixon, J C Wootton
The Biochemical Journal|September 1, 1993
Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase CS E Wilkinson, P J Parker, J S Nixon
Agents and Actions|January 1, 1993
Therapeutic potential of protein kinase C inhibitorsD Bradshaw, C H Hill, J S Nixon, et al.
Agents and Actions|January 1, 1986
The inhibitory profiles of hog pancreatic and human rheumatoid synovial cell phospholipases A2J S Nixon, S E Wilkinson, P Davis, et al.
Biochimica Et Biophysica Acta|July 27, 1989
1H-NMR and protection studies of interactions between ligands and bovine pancreatic phospholipase A2M P Williamson, P D Davis, M J Broadhurst, et al.
Cellular Signalling|January 1, 1997
Different sensitivities of neutrophil responses to a selective protein kinase C inhibitor Ro 31-8425; redundancy in signal transductionJ E Merritt, J A Sullivan, J Tse, et al.
Agents and Actions|March 1, 1991
Modulation of cellular processes by H7, a non-selective inhibitor of protein kinasesJ S Nixon, S E Wilkinson, P D Davis, et al.
Pageof 3